Watchtower Advisors’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-5,519
Closed -$1.73M 18
2025
Q2
$1.73M Hold
5,519
1.03% 18
2025
Q1
$1.68M Hold
5,519
1.22% 14
2024
Q4
$1.83M Sell
5,519
-25,838
-82% -$8.76M 1.04% 14
2024
Q3
$10.5M Hold
31,357
4.85% 9
2024
Q2
$12.9M Sell
31,357
-12,343
-28% -$4.89M 8.33% 5
2024
Q1
$17.7M Sell
43,700
-5,722
-12% -$2.01M 9.8% 4
2023
Q4
$15.1M Sell
49,422
-13,976
-22% -$3.77M 10.17% 5
2023
Q3
$15.4M Sell
63,398
-7,802
-11% -$2M 15.15% 5
2023
Q2
$17.1M Hold
71,200
9.21% 6
2023
Q1
$13.4M Hold
71,200
8.69% 6
2022
Q4
$15.1M Hold
71,200
8.93% 5
2022
Q3
$11.2M Buy
+71,200
New +$11.4M 8.69% 6

Other funds holding MEDP

Watchtower Advisors's MEDP Position: Q3 2025 in Review

Watchtower Advisors sold out of Medpace (MEDP) in Q3 2025, closing a stake of 5,519 shares — an estimated $1.73M sold.

Watchtower Advisors first reported a position in MEDP in Q3 2022 and held it in 12 quarters. The position peaked at $17.7M in Q1 2024. 672 funds tracked by Wall St. Rank hold MEDP as of Q3 2025.

  • Watchtower Advisors reported no remaining Medpace position as of Q3 2025 after selling out during the quarter.
  • Watchtower Advisors sold 5,519 Medpace shares in Q3 2025, an estimated $1.73M.
  • Watchtower Advisors first reported a position in Medpace in Q3 2022 and held it in 12 quarters.
  • Watchtower Advisors's Medpace position peaked at $17.7M in Q1 2024.
  • 672 funds tracked by Wall St. Rank held Medpace as of Q3 2025.

Based on Watchtower Advisors's 13F filing for Q3 2025, filed 13 Nov 2025.